Search Results - "Oostvogels, A A M"

Gene-expression-based T-Cell-to-Stroma Enrichment (TSE) score predicts response to immune checkpoint inhibitors in urothelial cancer by Rijnders, Maud, Nakauma-González, J. Alberto, Robbrecht, Debbie G. J., Gil-Jimenez, Alberto, Balcioglu, Hayri E., Oostvogels, Astrid A. M., Aarts, Maureen J. B., Boormans, Joost L., Hamberg, Paul, van der Heijden, Michiel S., Szabados, Bernadett E., van Leenders, Geert J. L. H., Mehra, Niven, Voortman, Jens, Westgeest, Hans M., de Wit, Ronald, van der Veldt, Astrid A. M., Debets, Reno, Lolkema, Martijn P.

“…Immune checkpoint inhibitors (ICI) improve overall survival in patients with metastatic urothelial cancer (mUC), but therapeutic success at the individual…”
Get full text

Case Report: Adequate T and B Cell Responses in a SARS-CoV-2 Infected Patient After Immune Checkpoint Inhibition by de Joode, K, Oostvogels, A A M, GeurtsvanKessel, C H, de Vries, R D, Mathijssen, R H J, Debets, R, van der Veldt, A A M

“…After the COVID-19 outbreak, non-evidence based guidelines were published to advise clinicians on the adjustment of oncological treatment during this pandemic…”
Get full text

CD45RA + CCR7 - CD8 T cells lacking co-stimulatory receptors demonstrate enhanced frequency in peripheral blood of NSCLC patients responding to nivolumab by Kunert, Andre, Basak, Edwin A, Hurkmans, Daan P, Balcioglu, Hayri E, Klaver, Yarne, van Brakel, Mandy, Oostvogels, Astrid A M, Lamers, Cor H J, Bins, Sander, Koolen, Stijn L W, van der Veldt, Astrid A M, Sleijfer, Stefan, Mathijssen, Ron H J, Aerts, Joachim G J V, Debets, Reno

“…Checkpoint inhibitors have become standard care of treatment for non-small cell lung cancer (NSCLC), yet only a limited fraction of patients experiences…”
Get full text

Serum cytokine levels are associated with tumor progression during FOLFIRINOX chemotherapy and overall survival in pancreatic cancer patients by van der Sijde, Fleur, Dik, Willem A, Mustafa, Dana A M, Vietsch, Eveline E, Besselink, Marc G, Debets, Reno, Koerkamp, Bas Groot, Haberkorn, Brigitte C M, Homs, Marjolein Y V, Janssen, Quisette P, Luelmo, Saskia A C, Mekenkamp, Leonie J M, Oostvogels, Astrid A M, Smits-Te Nijenhuis, Marja A W, Wilmink, Johanna W, van Eijck, Casper H J

“…Biomarkers predicting treatment response may be used to stratify patients with pancreatic ductal adenocarcinoma (PDAC) for available therapies. The aim of this…”
Get full text

A blood-based immune marker for resistance to pembrolizumab in patients with metastatic urothelial cancer by Rijnders, Maud, Robbrecht, Debbie G. J., Oostvogels, Astrid A. M., van Brakel, Mandy, Boormans, Joost L., Aarts, Maureen J. B., Balcioglu, Hayri E., Hamberg, Paul, Voortman, Jens, Westgeest, Hans M., Lolkema, Martijn P., de Wit, Ronald, van der Veldt, Astrid A. M., Debets, Reno

“…PD1 inhibition is effective in patients with metastatic urothelial cancer (mUC), yet a large fraction of patients does not respond. In this study, we aimed to…”
Get full text

Analyzing Flow Cytometry or Targeted Gene Expression Data Influences Clinical Discoveries—Profiling Blood Samples of Pancreatic Ductal Adenocarcinoma Patients by de Koning, Willem, van Eijck, Casper W. F, van der Sijde, Fleur, Strijk, Gaby J, Oostvogels, Astrid A. M, Debets, Reno, van Eijck, Casper H. J, Mustafa, Dana A. M

“…Introduction: Monitoring the therapeutic response of pancreatic ductal adenocarcinoma (PDAC) patients is crucial to determine treatment strategies. Several…”
Get full text

Anti-PD-1 Efficacy in Patients with Metastatic Urothelial Cancer Associates with Intratumoral Juxtaposition of T Helper-Type 1 and CD8 + T cells by Rijnders, Maud, Balcioglu, Hayri E, Robbrecht, Debbie G J, Oostvogels, Astrid A M, Wijers, Rebecca, Aarts, Maureen J B, Hamberg, Paul, van Leenders, Geert J L H, Nakauma-González, J Alberto, Voortman, Jens, Westgeest, Hans M, Boormans, Joost L, de Wit, Ronald, Lolkema, Martijn P, van der Veldt, Astrid A M, Debets, Reno

“…PD-1 inhibition results in durable antitumor responses in a proportion of patients with metastatic urothelial cancer (mUC). The majority of patients, however,…”
Get full text

Gestational diabetes mellitus among Sub-Saharan African and Surinamese women in the Netherlands by Rademaker, D., van Schaijik, C.I., Oostvogels, A.J.J.M., van Rijn, B.B., Evers, I., DeVries, J.H., Agyemang, C., Vrijkotte, T.G.M., Painter, R.C.

“…•Five to sevenfold higher risk of GDM in Ghanaian and other Sub-Saharan African women compared to ethnic Dutch women.•Higher risk of GDM in Surinamese women…”
Get full text

Maternal and paternal family history of diabetes in second-degree relatives and metabolic outcomes at age 5–6 years: The ABCD Study by Oostvogels, A.J.J.M, Landstra, C.P, Britsemmer, L, Lodewijkx, R, Stronks, K, Roseboom, T.J, Vrijkotte, T.G.M

“…Abstract Aim To investigate whether children with a family history of diabetes (FHD) in second-degree relatives (grandparents, aunts/uncles) are at increased…”
Get full text

Use of DALYs in economic analyses on interventions for infectious diseases: a systematic review by OOSTVOGELS, A. J. J. M., DE WIT, G. A., JAHN, B., CASSINI, A., COLZANI, E., DE WAURE, C., KRETZSCHMAR, M. E. E., SIEBERT, U., MÜHLBERGER, N., MANGEN, M.-J. J.

“…A systematic literature review was performed on full economic evaluations of infectious disease interventions using disability-adjusted life years (DALY) as…”
Get full text

Case Report: Adequate T and B Cell Responses in a SARS-CoV-2 Infected Patient After Immune Checkpoint Inhibition by de Joode, K, Oostvogels, A A M, GeurtsvanKessel, C H, de Vries, R D, Mathijssen, R H J, Debets, R, van der Veldt, A A M

Get full text